publication venue for
- Lung Cancer Survival Trends in the Veterans Health Administration.. 25:225-232. 2024
- So Now We Know-Reflections on the Extent of Resection for Stage I Lung Cancer.. 25:e113-e123. 2023
- Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer.. 23:236-243. 2022
- Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib.. 22:e851-e855. 2021
- The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.. 22:e84-e97. 2020
- Clinical Course of Hypertrophic Pulmonary Osteoarthropathy in a Patient Receiving Immune Checkpoint Inhibitor Therapy.. 21:e243-e245. 2020
- Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.. 21:255-263.e4. 2019
- Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer.. 18:50-59. 2016